PureTech Health (GB:PRTC) has released an update.
PureTech Health plc has announced a $100 million tender offer to repurchase its shares at 250 pence each, a 25% premium over the recent average share price, with the potential for a special dividend if the full amount is not tendered. This buyback represents around 12% of the company’s issued share capital, with the option for shareholders to tender some or all of their shares. The offer, conditional upon shareholder approval, highlights PureTech’s commitment to returning value to shareholders following the sale of its stake in Karuna Therapeutics.
For further insights into GB:PRTC stock, check out TipRanks’ Stock Analysis page.
